189 related articles for article (PubMed ID: 20149868)
1. Preparation and evaluation of spray-dried hyaluronic acid microspheres for intranasal delivery of fexofenadine hydrochloride.
Huh Y; Cho HJ; Yoon IS; Choi MK; Kim JS; Oh E; Chung SJ; Shim CK; Kim DD
Eur J Pharm Sci; 2010 Apr; 40(1):9-15. PubMed ID: 20149868
[TBL] [Abstract][Full Text] [Related]
2. Enhancing effect of surfactants on fexofenadine.HCl transport across the human nasal epithelial cell monolayer.
Lin H; Gebhardt M; Bian S; Kwon KA; Shim CK; Chung SJ; Kim DD
Int J Pharm; 2007 Feb; 330(1-2):23-31. PubMed ID: 16997520
[TBL] [Abstract][Full Text] [Related]
3. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
[TBL] [Abstract][Full Text] [Related]
4. Transport of anti-allergic drugs across the passage cultured human nasal epithelial cell monolayer.
Lin H; Yoo JW; Roh HJ; Lee MK; Chung SJ; Shim CK; Kim DD
Eur J Pharm Sci; 2005 Oct; 26(2):203-10. PubMed ID: 16087322
[TBL] [Abstract][Full Text] [Related]
5. Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes.
Gungor S; Okyar A; Erturk-Toker S; Baktir G; Ozsoy Y
Drug Dev Ind Pharm; 2010 Jul; 36(7):806-13. PubMed ID: 20136490
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.
Sheshala R; Peh KK; Darwis Y
Drug Dev Ind Pharm; 2009 Nov; 35(11):1364-74. PubMed ID: 19832637
[TBL] [Abstract][Full Text] [Related]
7. Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies.
Gavini E; Hegge AB; Rassu G; Sanna V; Testa C; Pirisino G; Karlsen J; Giunchedi P
Int J Pharm; 2006 Jan; 307(1):9-15. PubMed ID: 16257156
[TBL] [Abstract][Full Text] [Related]
8. Formulation and in vitro evaluation of a PEGylated microscopic lipospheres delivery system for ceftriaxone sodium.
Attama AA; Okafor CE; Builders PF; Okorie O
Drug Deliv; 2009 Nov; 16(8):448-57. PubMed ID: 19839789
[TBL] [Abstract][Full Text] [Related]
9. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome.
Qiang F; Shin HJ; Lee BJ; Han HK
Int J Pharm; 2012 Jul; 430(1-2):161-6. PubMed ID: 22525082
[TBL] [Abstract][Full Text] [Related]
10. Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride.
Cho HJ; Balakrishnan P; Park EK; Song KW; Hong SS; Jang TY; Kim KS; Chung SJ; Shim CK; Kim DD
J Pharm Sci; 2011 Feb; 100(2):681-91. PubMed ID: 20803575
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres.
Abdel Mouez M; Zaki NM; Mansour S; Geneidi AS
Eur J Pharm Sci; 2014 Jan; 51():59-66. PubMed ID: 23999035
[TBL] [Abstract][Full Text] [Related]
12. Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide.
Gavini E; Rassu G; Muzzarelli C; Cossu M; Giunchedi P
Eur J Pharm Biopharm; 2008 Feb; 68(2):245-52. PubMed ID: 17574825
[TBL] [Abstract][Full Text] [Related]
13. Design and development of nasal mucoadhesive microspheres containing tramadol HCl for CNS targeting.
Belgamwar VS; Patel HS; Joshi AS; Agrawal A; Surana SJ; Tekade AR
Drug Deliv; 2011 Jul; 18(5):353-60. PubMed ID: 21351825
[TBL] [Abstract][Full Text] [Related]
14. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis.
Abdelaziz MM; Devalia JL; Khair OA; Bayram H; Prior AJ; Davies RJ
J Allergy Clin Immunol; 1998 Mar; 101(3):410-20. PubMed ID: 9525460
[TBL] [Abstract][Full Text] [Related]
15. Formulation, optimization and evaluation of spray-dried mucoadhesive microspheres as intranasal carriers for Valsartan.
Pardeshi CV; Rajput PV; Belgamwar VS; Tekade AR
J Microencapsul; 2012; 29(2):103-14. PubMed ID: 22047546
[TBL] [Abstract][Full Text] [Related]
16. Alginate microspheres of isoniazid for oral sustained drug delivery.
Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable heparin-loaded microspheres: carrier molecular composition and microsphere structure.
Luo X; Qiu D; He B; Wang L; Luo J
Macromol Biosci; 2006 May; 6(5):373-81. PubMed ID: 16685689
[TBL] [Abstract][Full Text] [Related]
18. Oxprenolol-loaded bioadhesive microspheres: preparation and in vitro/in vivo characterization.
Preda M; Leucuta SE
J Microencapsul; 2003; 20(6):777-89. PubMed ID: 14594666
[TBL] [Abstract][Full Text] [Related]
19. Chitosan microspheres as a delivery system for nasal insufflation.
Patil SB; Sawant KK
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):384-9. PubMed ID: 21320767
[TBL] [Abstract][Full Text] [Related]
20. Enhanced oral bioavailability of piroxicam in rats by hyaluronate microspheres.
Piao MG; Kim JH; Kim JO; Lyoo WS; Lee MH; Yong CS; Choi HG
Drug Dev Ind Pharm; 2007 Apr; 33(4):485-91. PubMed ID: 17523012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
